Independent Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Sell
1,248
-373
-23% -$77.3K ﹤0.01% 1366
2026
Q1
$364K Buy
1,621
+3
+0.2% +$748 0.01% 1070
2025
Q4
$390K Buy
1,618
+30
+2% +$7.67K 0.01% 1020
2025
Q3
$435K Sell
1,588
-90
-5% -$24.6K 0.01% 917
2025
Q2
$433K Buy
1,678
+23
+1% +$5.49K 0.01% 842
2025
Q1
$370K Buy
1,655
+217
+15% +$50.7K 0.01% 841
2024
Q4
$329K Buy
+1,438
New +$346K 0.01% 867

Other funds holding RMD

Independent Financial Group's RMD Position: Q2 2026 in Review

Independent Financial Group reduced its ResMed (RMD) stake by 23% in Q2 2026, selling an estimated $77.3K and leaving 1,248 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Independent Financial Group first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $435K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Independent Financial Group held 1,248 shares of ResMed worth $243K as of Q2 2026.
  • Independent Financial Group sold 373 ResMed shares in Q2 2026, an estimated $77.3K.
  • ResMed made up ﹤0.01% of Independent Financial Group's portfolio in Q2 2026, its #1366 holding.
  • Independent Financial Group first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Independent Financial Group's ResMed position peaked at $435K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.